Uncertainties in measurement of 90Y and 177Lu activities in an ionisation chamber

被引：0
|
作者：
Ballinger, J. R. [1 ]
Fernandez, R. [1 ]
Allen, S. J. [1 ]
机构：
[1] Guys & St Thomas Hosp, London SE1 9RT, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [21] Quantitative Imaging of 177Lu in the Presence of 90Y for Peptide Receptor Radionuclide Therapy: A Simulation Study
    Miller, C.
    Rahmim, A.
    Uribe-munoz, C.
    Celler, A.
    MEDICAL PHYSICS, 2020, 47 (06) : E550 - E550
  • [22] Anaerobic 90Y and 177Lu labeling of a DOTA-conjugated nonpeptide vitronectin receptor antagonist.
    Liu, S
    Ellars, C
    Edwards, DS
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 372P - 372P
  • [23] Individual dosimetry and monitoring response to treatment in tandem PRRT with [177Lu/90Y]-DOTA-TATE
    Kacperski, Krzysztof
    Budzynska, Anna
    Kubik, Agata
    Pastusiak, Patrycja
    Chalewska, Wioletta
    Lenda-Tracz, Wioletta
    Borkowska, Anna
    Walecka-Mazur, Agata
    Szczodry, Artur
    Braziewicz, Janusz
    Kolodziej, Maciej
    Kaminski, Grzegorz
    Dedecjus, Marek
    Dlugosinska, Joanna
    Januszkiewicz-Caulier, Joanna
    Hubalewska-Dydejczyk, Alicja
    Opalinska, Marta
    Kowalska, Aldona
    Mikolajczak, Renata
    POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING, 2024, 30 (04):
  • [24] Optimized cocktail of 90Y/177Lu for radionuclide therapy of neuroendocrine tumors of various sizes: a simulation study
    Peer-Firozjaei, Milad
    Tajik-Mansoury, Mohammad Ali
    Geramifar, Parham
    Ghorbani, Raheb
    Zarifi, Shiva
    Miller, Cassandra
    Rahmim, Arman
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (06) : 646 - 655
  • [25] COSTBM0607-WG2, Preparation of therapeutic doses of 177Lu or 90Y DOTATATE for PRRT
    Pawlak, Dariusz
    Wojdowska, Wioletta
    Mikolajczak, Renata
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 723 - 723
  • [26] Production of glass microspheres comprising 90Y and 177Lu for treating of hepatic tumors with SPECT imaging capabilities
    Poorbaygi, Hosein
    Aghamiri, Seyed Mahmoud Reza
    Sheibani, Shahab
    Kamali-asl, Alireza
    Mohagheghpoor, Elham
    APPLIED RADIATION AND ISOTOPES, 2011, 69 (10) : 1407 - 1414
  • [27] Investigation of the influence of metallic impurities on the 90Y and 177Lu labelling yield of DOTA and DOTA-TATE
    Pawlak, D
    Korsak, A
    Mikolajczak, R
    Sasinowska, I
    Parus, JL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S388 - S388
  • [28] 90Y and 177LU labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy
    Liu, S
    Cheung, E
    Ziegler, MC
    Rajopadhye, M
    Edwards, DS
    BIOCONJUGATE CHEMISTRY, 2001, 12 (04) : 559 - 568
  • [29] Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using 90Y or 177Lu
    Kang, Chi Soo
    Chen, Yunwei
    Lee, Hyunbeom
    Liu, Dijie
    Sun, Xiang
    Kweon, Junghun
    Lewis, Michael R.
    Chong, Hyun-Soon
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (03) : 242 - 249
  • [30] Clinical peptide receptor radionuclide therapy: Kit preparation of 90Y, 177Lu, and 111In DOTATATE
    Ballinger, J. R.
    Tan, Y.
    Allen, S. J.
    Lewington, V. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S425 - S425
12345